Growth hormone, insulin-like growth factor-1 and the aging cardiovascular system

Cardiovascular Research

Volumn 54, Issue 1, 2002, Pages 25-35

  Watzinger, Norbert ^a,c   Lund, Gunnar K ^a   Higgins, Charles B ^a   Chujo, Mitsuaki ^b   Saeed, Maythem ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CHUGAI PHARMACEUTICAL CO LTD   (Japan)

^c UNIVERSITY OF GRAZ   (Austria)

Author keywords

Ageing; Growth factors; Hormones

Indexed keywords

BETA ADRENERGIC RECEPTOR; COLLAGEN; GROWTH HORMONE; SOMATOMEDIN C;

AGING; ARTERY COMPLIANCE; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR SYSTEM; CATABOLISM; CONGESTIVE HEART FAILURE; CORONARY ARTERY BLOOD FLOW; EXERCISE; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; HEART CONDUCTION; HEART FUNCTION; HEART MUSCLE FIBROSIS; HEART STRESS; HORMONAL REGULATION; HORMONAL THERAPY; HORMONE BLOOD LEVEL; HUMAN; IMMUNITY; LEAN BODY WEIGHT; LEARNING; MEMORY; NONHUMAN; OBESITY; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SKELETAL MUSCLE; TISSUE REACTION;

AGED; AGING; ANIMALS; CARDIOVASCULAR PHYSIOLOGY; GROWTH HORMONE; HEART FAILURE, CONGESTIVE; HUMANS; HYPOTHALAMUS; INSULIN-LIKE GROWTH FACTOR I; MODELS, ANIMAL; RATS; RATS, INBRED STRAINS;

EID: 0036216215     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(01)00533-8     Document Type: Review

References (81)

1. Isolation and properties of the anterior hypophysial growth hormone
2. Age-related change in the 24-h spontaneous secretion of growth hormone
3. Human growth hormone and human aging
4. Effects of growth hormone-releasing hormone and somatostatin on sleep EEG and nocturnal hormone secretion in male controls
5. The significance of sleep onset and slow wave sleep for nocturnal release of growth hormone (GH) and cortisol
6. Evidence for an endogenous ultradian rhythm governing growth hormone secretion in the rat
7. Isolation, primary structure, and synthesis of human hypothalamic somatocrinin: Growth hormone-releasing factor
8. Characterization of a growth hormone-releasing factor from a human pancreatic islet tumour
9. Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone
10. The interrelationship of growth hormone (GH)-releasing factor and somatostatin in generation of the ultradian rhythm of GH secretion
11. Circulating growth hormone binding proteins
12. Rational design of potent antagonists to the human growth hormone receptor
13. The insulin-like growth factors
14. Growth hormone induces somatostatin and insulin-like growth factor I gene expression in the cerebral hemispheres of aging rats
15. Differential effects of estrogen and growth hormone on uterine and hepatic insulin-like growth factor I gene expression in the ovariectomized hypophysectomized rat
16. Enzymatic conversion of IGF-I to des(1-3)IGF-I in rat serum and tissues: A further potential site of growth hormone regulation of IGF-I action
17. The somatomedin hypothesis: 2001
18. Somatomedin (insulin-like growth factors)-binding proteins. Molecular forms and regulation
19. A personal history of the origin of the somatomedin hypothesis and recent challenges to its validity
20. Action of growth hormone: Current views
21. Plasma growth hormone in men and women over 70 years of age
22. Absence of sleep-related growth hormone peaks in aged normal subjects and in acromegaly
23. Low somatomedin-C levels in older men rise in response to growth hormone administration
24. Impaired growth hormone secretion in the adult population: Relation to age and adiposity
25. Decreased pulsatile release of growth hormone in old male rats
26. Effect of rat age on serum levels of growth hormone and somatomedins
27. Impaired ability of old male rats to secrete growth hormone in vivo but not in vitro in response to hpGRF(1-44)
28. Age-related changes in plasma growth hormone response to growth hormone-releasing factor in man
29. Diminished pituitary responsiveness to growth hormone-releasing factor in aging male rats
30. Growth hormone releasing hormone induced release of growth hormone in old male rats: Dependence on pharmacological manipulation and endogenous somatostatin release
31. Effect of aging on GHRF induced release of growth hormone from anterior pituitary cells in primary culture
32. Effect of CNS active drugs and somatostatin antiserum on growth hormone release in young and old rats
33. Increased secretion of somatostatin-28 from hypothalamic neurons of aged rats in vitro
34. Activation of cholinergic neurotransmission by pyridostigmine reverses the inhibitory effect of hyperglycemia on growth hormone (GH) releasing hormone-induced GH secretion in man: Does acute hyperglycemia act through hypothalamic release of somatostatin?
35. Growth hormone (GH) responsiveness to combined administration of arginine and GH-releasing hormone does not vary with age in man
36. Reduced growth hormone releasing factor (GHRF)-like immunoreactivity and GHRF gene expression in the hypothalamus of aged rats
37. Feedback effects of growth hormone on growth hormone-releasing hormone and somatostatin are not evident in aged rats
38. The insulin-like growth factor I generation test: Resistance to growth hormone with aging and estrogen replacement therapy
39. GH binding to liver in young and old female rats: Relation to somatomedin-C secretion
40. Decreases in growth hormone receptor signal transduction contribute to the decline in insulin-like growth factor I gene expression with age
41. Stimulation by growth hormone of MAP kinase activity in 3T3-F442A fibroblasts
42. Postreceptor signaling mechanisms for growth hormone
43. Growth hormone rapidly activates insulin-like growth factor I gene transcription in vivo
44. Insulin-like growth factor-1 stimulation of protein synthesis is attenuated in cerebral cortex of aging rats
45. Effect of aging on insulin receptor, insulin receptor substrate-1, and phosphatidylinositol 3-kinase in liver and muscle of rats
46. Growth hormone-induced nuclear translocation of Stat-3 decreases with age: Modulation by caloric restriction
47. Biochemistry and pharmacology of rabbit cardiac growth hormone (GH) receptors
48. Regulation of rat growth hormone receptor gene expression
49. Growth hormone receptors and action in BC3H-1 myocytes
50. Differential regulation of insulin-like growth factor I by growth hormone and thyroid hormone in the heart of juvenile hypophysectomized rats
51. Effects of growth hormone supplementation on left ventricular morphology and myocyte function with the development of congestive heart failure
52. Insulin-like growth factor receptor-1 stimulates phosphorylation of the β2-adrenergic receptor in vivo on sites distinct from those phosphorylated in response to insulin
53. Elevated blood pressure and enhanced myocardial contractility in mice with severe IGF-1 deficiency
54. Decreases in cerebral microvasculature with age are associated with the decline in growth hormone and insulin-like growth factor 1
55. Growth hormone enhances regional coronary blood flow and capillary density in aged rats
56. Growth hormone reverses age-related cardiac myofilament dysfunction in aged rats
57. Differential cardiac effects of growth hormone and insulin-like growth factor-1 in the rat. A combined in vivo and in vitro evaluation
58. 2+ handling and enhance cardiac performance. In vitro evaluation in the isolated isovolumic buffer-perfused rat heart
59. 2+ through a wortmannin-sensitive pathway: Studies in rat and ferret isolated muscles
60. Reversible dilated cardiomyopathy due to growth hormone deficiency
61. Growth hormone improves cardiac performance in experimental heart failure
62. Progressive cardiac dysfunction and fibrosis in the cardiomyopathic hamster and effects of growth hormone and angiotensin-converting enzyme inhibition
63. Identification of the Syrian hamster cardiomyopathy gene
64. Both hypertrophic and dilated cardiomyopathies are caused by mutation of the same gene, delta-sarcoglycan, in hamster: An animal model of disrupted dystrophin-associated glycoprotein complex
65. Treatment with growth hormone enhances contractile reserve and intracellular calcium transients in myocytes from rats with postinfarction heart failure
66. Body composition, bone metabolism, and heart structure and function in growth hormone (GH)-deficient adults before and after GH replacement therapy at low doses
67. Long-term cardiovascular effects of growth hormone treatment in GH-deficient adults. Preliminary data in a small group of patients
68. Impaired spontaneous growth hormone secretion in severe dialated cardiomyopathy
69. Recombinant growth hormone therapy in patients with ischemic cardiomyopathy: Effects on hemodynamics, left ventricular function, and cardiopulmonary exercise capacity
70. Does growth hormone prevent or accelerate aging?
71. Importance of an intact growth hormone/insulin-like growth factor 1 axis for normal postinfarction healing: Studies in dwarf rats
72. Echocardiographic assessment of cardiac morphology and function in mutant dwarf rats
73. Intrinsic cardiac muscle function, calcium handling and β-adrenergic responsiveness is impaired in rats with growth hormone deficiency
74. Growth hormone restores protein synthesis in skeletal muscle of old male rats
75. Effects of human growth hormone in men over 60 years old
76. GH3 pituitary adenoma cells can reverse thymic aging in rats
77. Role of growth hormone in regulating T-dependent immune events in aged, nude, and transgenic rodents
78. Dose-dependent effects of recombinant human growth hormone on biochemical markers of bone and collagen metabolism in adult growth hormone deficiency
79. Treatment of postmenopausal osteoporosis with recombinant human growth hormone and salmon calcitonin: A placebo controlled study
80. Effects of recombinant human growth hormone and insulin-like growth factor-I, with or without 17β-estradiol, on bone and mineral homeostasis of aged ovariectomized rats
81. Determination of insulin-like growth factor-I in the monitoring of growth hormone treatment with respect to efficacy of treatment and side effects: Should potential risks of cardiovascular disease and cancer be considered?